| Literature DB >> 33511555 |
Guizhen Wang1,2, Qun Zhao1,3, Hui Zhang4, Fan Liang1,2, Chen Zhang1,2, Jun Wang5, Zhenyin Chen1,6, Ran Wu1,6, Hong Yu7, Beibei Sun1, Hua Guo1, Ruie Feng4, Kaifeng Xu5, Guangbiao Zhou8.
Abstract
An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4%-18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2 infection. Here, we show that cigarette smoke extract (CSE) and carcinogen benzo(a)pyrene (BaP) increase ACE2 mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor (AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice. Tobacco carcinogens inhibit SARS-CoV-2 spike protein pseudovirions infection of the cells. Given that tobacco smoke accounts for 8 million deaths including 2.1 million cancer deaths annually and Skp2 is an oncoprotein, tobacco use should not be recommended and cessation plan should be prepared for smokers in COVID-19 pandemic.Entities:
Keywords: ACE2; SARS-CoV-2; Skp2; benzo(a)pyrene; tobacco smoke
Year: 2021 PMID: 33511555 PMCID: PMC7843238 DOI: 10.1007/s11684-021-0837-6
Source DB: PubMed Journal: Front Med ISSN: 2095-0217 Impact factor: 4.592